Lupin slips 5% as USFDA classifies Goa facility's inspection as OAI
The USFDA stated that Goa facility may be subject to regulatory or administrative action and that it may withhold approval of any pending applications or supplements in which this facility is listed.
The USFDA stated that Goa facility may be subject to regulatory or administrative action and that it may withhold approval of any pending applications or supplements in which this facility is listed. http://bit.ly/2K3sM1v May 26, 2019 at 06:29PM
The USFDA stated that Goa facility may be subject to regulatory or administrative action and that it may withhold approval of any pending applications or supplements in which this facility is listed. http://bit.ly/2K3sM1v May 26, 2019 at 06:29PM
Comments
Post a Comment